PyInvesting

Market research

6CQ.F Cresco Labs Inc

F EUR Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
222M
P/E ratio
Not available
Analyst target
14.41
Dividend yield
Not available
Beta
1.77

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Cresco Labs Inc is currently in a long term downtrend where the price is trading 2.1% below its 200 day moving average.

From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.8.

Cresco Labs Inc's total revenue rose by 312.8% to $171M since the same quarter in the previous year.

Its net income has dropped by 72.1% to $-48M since the same quarter in the previous year.

Finally, its free cash flow grew by 113.2% to $6M since the same quarter in the previous year.

Based on the above factors, Cresco Labs Inc gets an overall score of 3/5.